Hims & Hers Health’s stock jumped more than 30% Monday morning after the health and wellness platform said it would offer compounded versions of popular GLP-1 drugs.
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Read Next
- Speculator Bets led by Live Cattle, Lean Hogs & Coffee :: InvestMacro
- Speculator Bets led lower by Gold, Copper & Palladium :: InvestMacro
- If you want to stay in excellent physical and mental shape as you get older, say goodbye to these 7 behaviors
- New Zealand Dollar, Euro & CAD lead Bearish Positions :: InvestMacro
- Speculator Bets led by SOFR 3-Months & 10-Year Bonds :: InvestMacro
- Speculator Bets led by S&P500 & Russell-2000 :: InvestMacro
- Men who grew up with temperamental and immature fathers usually display these 7 behaviors later in life
